2013•Sichuan Medical JournalRequires access
VATS lobectomy clinical value in the treatment of non-small cell lung cancer
Cao Jian-bi
Open publisher page 0 citations
Abstract
Objective To observe the VATS lobectomy clinical value in the treatment of non-small cell lung cancer.Methods October 2008 to October 2011,60 cases of non-small cell lung cancer patients who underwent surgical treatment,were randomly divided into observation group and the control group,30 patients in each.The observation group thoracoscopic lobectomy hand treatment,control group using the traditional thoracotomy lobe resection.Results incision length of the observation group(7.4±2.8)cm,blood loss(201±75)ml,the removal of lymph nodes(14±8),operative time(220±55)min,control group(25.8±3.5)cm,(305±140)ml,(15±7)a,(202±50)min;two sets of incision length,blood loss,P0.05.Postoperative drainage time of the observation group(2.2±1.4)d,the analgesic time(1.8±2.0)d,length of hospital stay(7.6±2.9)d,the control group,respectively(4.9±1.5),(4.6±2.9),(16.5±4.6)d;groups,P0.05.Postoperative follow-up of more than one year,the observation group 1 died,1-year survival rate was 96.7%;control group,2 patients died,1-year survival rate was 93.3%;compare two sets of survival(P0.05).Conclusion VATS lobectomy for non-small cell lung cancer is safe and effective.